KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Common Equity (2016 - 2025)

Historic Common Equity for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $24.5 billion.

  • Boston Scientific's Common Equity rose 1122.12% to $24.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.5 billion, marking a year-over-year increase of 1122.12%. This contributed to the annual value of $24.5 billion for FY2025, which is 1122.12% up from last year.
  • Per Boston Scientific's latest filing, its Common Equity stood at $24.5 billion for Q4 2025, which was up 1122.12% from $23.6 billion recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Common Equity peaked at $24.5 billion during Q4 2025, and registered a low of $15.7 billion during Q1 2021.
  • For the 5-year period, Boston Scientific's Common Equity averaged around $19.3 billion, with its median value being $18.8 billion (2023).
  • In the last 5 years, Boston Scientific's Common Equity tumbled by 1862.17% in 2021 and then soared by 1276.01% in 2025.
  • Quarter analysis of 5 years shows Boston Scientific's Common Equity stood at $16.6 billion in 2021, then rose by 5.72% to $17.6 billion in 2022, then rose by 11.14% to $19.5 billion in 2023, then increased by 12.66% to $22.0 billion in 2024, then grew by 11.22% to $24.5 billion in 2025.
  • Its last three reported values are $24.5 billion in Q4 2025, $23.6 billion for Q3 2025, and $22.7 billion during Q2 2025.